FDA approval means children with diabetes can skip mealtime injections and manage blood sugar with a simple inhaler instead.
The FDA just approved Afrezza inhaled insulin for kids as young as 6 with diabetes. Instead of multiple daily shots, children breathe in a powder that works faster than injections—starting immediately and clearing their system within an hour. This matters because traditional rapid-acting insulin takes 15 minutes to kick in and lingers for 2-3 hours, making corrections impossible during that window.
For kids who already deal with the social stigma of diabetes, eliminating visible injections removes another layer of complexity. They can eat birthday cake without calculating whether it's worth another shot. They don't miss track meets waiting for insulin to kick in. And parents stop worrying about injection site bruising when their child has limited body fat for rotation.
This isn't a complete replacement for current diabetes management. Kids still need their nightly long-acting insulin shot and continuous glucose monitoring. But reducing daily injections from seven to one fundamentally changes how families navigate school, sports, and social situations while keeping blood sugar stable.
What You Can Actually Do Today
- Ask your child's endocrinologist if inhaled insulin could reduce their daily injection burden
- Research insurance coverage for Afrezza since it may not be automatically covered yet
- Connect with diabetes support groups to hear from other families using inhaled insulin
Diabetes medication changes require medical supervision. Work with your child's endocrinologist to evaluate treatment options.
